IL-17, similar to TLRs, can trigger NF-κB and MAPK signaling pathways to induce downstream genes, thereby promoting the progression of autoimmune diseases, host defense, and tumor progression [48,49]. This evidence concerns the gene NFKB1 and autoimmune disease.